BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors
Are you struggling to find investors, funding, collaborators, and strategic connections in the ever-changing world of biotech?
This show empowers bio…
Feb 4th, 2026 |
00:00
Episode 122: Investing Where It Matters Most in Biotech – Venture Capital and the Future of Pediatric Care
How do you build a venture strategy that both delivers strong returns and meaningfully improves the lives of children and families?
In this episode, host Elaine Hamm, PhD, sits down with Andrew Meadow, MBA, Founding Partner and Chief Investment Officer at Health Innovation Capital, for a thoughtful conversation about investing in pediatric and maternal health. Andrew shares the personal and professional journey that led him to focus his career on underserved pediatric populations, and why children are not just “small adults” when it comes to innovation, clinical development, and investment strategy.
In this episode, you’ll learn:
Tune in to hear how purpose-driven venture capital can change the trajectory of healthcare innovation and why investing in children may be one of the most important bets biotech can make.
Links:
Connect with Andrew Meadow, MBA, and check out Health Innovation Capital.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
In this episode, host Elaine Hamm, PhD, sits down with Andrew Meadow, MBA, Founding Partner and Chief Investment Officer at Health Innovation Capital, for a thoughtful conversation about investing in pediatric and maternal health. Andrew shares the personal and professional journey that led him to focus his career on underserved pediatric populations, and why children are not just “small adults” when it comes to innovation, clinical development, and investment strategy.
In this episode, you’ll learn:
- Why pediatric and maternal health remain some of the most underfunded (and high impact) areas in biotech.
- How venture funds can balance financial returns with real-world improvements in access, affordability, and quality of care.
- What entrepreneurs need to know to engage pediatric-focused investors and stand out in a competitive funding environment.
Tune in to hear how purpose-driven venture capital can change the trajectory of healthcare innovation and why investing in children may be one of the most important bets biotech can make.
Links:
Connect with Andrew Meadow, MBA, and check out Health Innovation Capital.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU - the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.